CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 144 Insider Sale of Securities
- 4 Open-market sale President and COO sold 3,991 shares at an average $380.43 ($1,518,303)
- 8-K Event Material agreement · New debt or obligation
- 144 Insider Sale of Securities
- 4 Open-market sale President and COO sold 16,009 shares at an average $365.22 ($5,846,820)
- 4 Planned sale SVP, General Counsel sold 996 shares at an average $349.17 ($347,770)
- 4 Gift Chief Executive Officer gave 1,009,853 shares (gift)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Gift Director gave 424,073 shares (gift)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale SVP, General Counsel sold 10,671 shares at an average $350.40 ($3,739,108)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 27,803 shares at an average $325.71 ($9,055,694)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SVP, General Counsel sold 10,006 shares at an average $325.53 ($3,257,289)
- 4 Gift Director gave 148,096 shares (gift)
- 4 Planned sale Global Head of R&D sold 5,000 shares at $350.06 ($1,750,312)
Page 8 of 64 · 1,278 filings